MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Longitudinal predictors of quality of life in Parkinson’s disease: analysis of NILS cohort data at four years follow up

    C. Rodriguez-Blazquez, MJ. Forjaz, A. Rizos, P. Martinez-Martin, KR. Chaudhuri (Madrid, Spain)

    Objective: To analyze the change in quality of life (QoL) and its longitudinal predictors in a sample of Parkinson’s disease (PD) patients. Background: Natural progression…
  • 2022 International Congress

    Non-apoptotic caspase-3 activation mediates early synaptic dysfunction of indirect pathway neurons in the parkinsonian striatum

    C. Li, T. Fieblinger, E. Espa, MA. Cenci (Lund, Sweden)

    Objective: We set out to investigate whether caspase-3 plays a role in the loss of dendritic spines and the concomitant synaptic deficits that develop in…
  • 2022 International Congress

    Multimodal assessment of nigrostriatal degeneration in de novo Parkinson’s disease

    M. López-Aguirre, M. Matarazzo, J. Blesa, A. Sánchez-Ferro, M. Hm Monje, J. Obeso, J. Pineda-Pardo (Móstoles, Spain)

    Objective: To study nigrostriatal changes with a multifactorial neuroimaging approach in order to further characterize early abnormalities in Parkinson’s Disease (PD). Background: Imaging techniques allow…
  • 2022 International Congress

    Quality of Life in African American and White Parkinson’s Disease Patients

    D. Hall, S. Anderson, G. Stebbins, L. Barnes, M. Bailey, L. Shulman (Chicago, USA)

    Objective: To determine the quality of life of African American (AA) and White patients with Parkinson’s disease (PD) at the Rush University Medical Center (RUMC)…
  • 2022 International Congress

    Nutritional Status in Advanced Parkinson’s Disease: Preliminary Results.

    N. Ayo (Barakaldo, Spain)

    Objective: To analyze the relationship between nutritional intake and weight aspects in 3 groups of patients with Parkinson's disease (PD) who are receiving different pharmacological…
  • 2022 International Congress

    Exploratory analysis of the effect of delayed-start prasinezumab on motor sign progression measured with the Roche PD Mobile Application v2: PASADENA Phase II Parts 1 and 2

    K. Taylor, F. Lipsmeier, E. Volkova-Volkmar, M. Scelsi, L. Essioux, A. Monnet, B. van Lier, H. Svoboda, T. Kustermann, W. Zago, T. Nikolcheva, R. Postuma, G. Pagano, M. Lindemann (Basel, Switzerland)

    Objective: To determine whether the positive effects of prasinezumab on motor progression measured by Roche PD Mobile Application (PASADENA study Part 1; 0-52 weeks; NCT03100149)…
  • 2022 International Congress

    Effect of CDNF in a novel combination stressor model of Parkinson’s disease

    A. Singh, A. Panhelainen, M. Voutilainen (Helsinki, Finland)

    Objective: In this study, our first aim was to develop a model for Parkinson's disease (PD) that would exhibit the alpha-synuclein (αSyn) aggregation pathology and…
  • 2022 International Congress

    A fully immersive virtual reality environment to study gait modulation in Parkinson’s disease

    I. Hanafi, P. Kullmann, IU. Isaias, C. Palmisano (Würzburg, Germany)

    Objective: To investigate the safety and efficacy of a fully immersive virtual reality (VR) paradigm to study gait modulation in subjects with Parkinson’s disease (PD).…
  • 2022 International Congress

    Prediction of early-stage Parkinson’s disease using connectivity and morphometry of the striatum

    D. Henadeerage Don, E. Alushaj, N. Handfield-Jones4, A. Khan, P. Macdonald (London, Canada)

    Objective: To parcellate the striatum into sub-regions and extract connectivity and surface morphometry features that can distinguish early patients with PD using machine learning. Background:…
  • 2022 International Congress

    Initial experience with levodopa-entacapone-carbidopa intestinal gel infusion (LECIG) for the management of advanced Parkinson’s disease in Slovenia

    E. Pipan, N. Zupančič Križnar, L. Ocepek, R. Rajnar, M. Kramberger, M. Menih, Z. Pirtošek, M. Trošt (Ljubljana, Slovenia)

    Objective: To study the initial experience with levodopa-entacapone-carbidopa intestinal gel infusion (LECIG) in routine clinical practice at two University Medical Centers in Slovenia. Background: The…
  • « Previous Page
  • 1
  • …
  • 263
  • 264
  • 265
  • 266
  • 267
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Movement disorders in chronic obstructive pulmonary disease (COPD); the effect of pulmonary disease to brain
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley